Studies of breast cancer cells demonstrated that miR-200a represses the expression of TFAM (mitochondrial transcription factor A), the principal transcription factor of mitochondria [41], an effect that hampers the proliferative capacity of cells. Here, TFAM is linked to breast carcinoma.